Prevalence and risk factors of Helicobacter pylori-negative peptic ulcer: A multicenter study

Journal of Clinical Gastroenterology

Volumn 31, Issue 1, 2000, Pages 42-47

  Meucci, Gianmichele ^b   Di Battista, Roberto ^a   Abbiati, Carla ^a   Benassi, Rossella ^c   Bierti, Luigi ^a   Bortoli, Aurora ^d   Colombo, Enrico ^e   Ferrara, Aldo ^f   Prada, Alberto ^d   Spinzi, Giancarlo ^b   Venturelli, Renato ^g   De Franchis, Roberto ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b VALDUCE HOSPITAL   (Italy)

^c Digestive Endoscopy Centre   (Italy)

^d RHO HOSPITAL   (Italy)

^e SANTA CORONA HOSPITAL   (Italy)

^f Ospedale di Legnano   (Italy)

^g Ospedale di Edolo   (Italy)

Author keywords

Attributable risk; Helicobacter pylori; Helicobacter pylori negative; Peptic ulcer

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; FEMALE; GASTROINTESTINAL BIOPSY; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PEPTIC ULCER; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; DUODENAL ULCER; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER; PREVALENCE; RISK FACTORS;

EID: 0033923657     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200007000-00010     Document Type: Article

References (19)

1. Kuipers EJ, Thijs JC, Festen HPM. The prevalence of Helicobacter pylori in peptic ulcer. Aliment Pharmacol Ther 1995;9(suppl 2):59-69.
2. Lam SK, Ching GK, Lai KC, et al. Does treatment of Helicobacter pylori with amibiotics alone heal duodenal ulcer? A randomised double blind placebo controlled study. Gut 1997;41:43-8.
3. Tytgat GNJ. Review article: treatments that impact favorably upon the cradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994;8:359-68.
4. Pounder RE. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 1995;9(suppl 2):33-9.
5. Anand BS, Raed AK, Malaty HM, et al. Low point, prevalence of peptic ulcer in normal individuals with Helicobacter pylori infection. Am J Gastroenterol 1996;6:112-5.
6. Peterson WL, Ciocciola AA, Sykes DL, McSorley DJ, Webb DD, the RBC H Pylori Study Group. Ranitidine bismuth citrate plus clarithromicin is effective for healing duodenal ulcers, eradicating H-Pylori and reducing ulcer recurrence. Aliment Pharmacol Ther 1996;10:251-61.
7. Laine L, Hopkins RJ, Ginirdi LS, Rockville FDA. Has the impact pf H. pylori therapy on duodenal ulcer recurrence in the U.S. been overstated? A metaanalysis of rigorously-designed trials [abstract]. Gastroenterology 1997;112: A192.
8. Logan RPH, Bardhan KD, Celestin LR, et al. Eradication of Helicobacter pylori and prevention of recurrence of duodenal ulcer: a randomized, double-blind, multicenter trial of omeprazole with or without clarithromicin. Aliment Pharmacol Ther 1995;9:417-23.
9. Pounder R. Duodenal ulcers that are difficult to heal. BMJ 1988;297:1560-1.
10. Armitage P, Berry G. Statistical methods in medical research. Oxford, UK: Blackwell Science Ltd, 1994.
11. Gasharrini G, Pretolani S, Bonvicini F, et al. A population based study of Helicobacter pylori infection in a European country: the San Marino Study. Relations with gastrointestinal diseases. Gut 1995;36:838-44.
12. McColl KEL, El-Nujumi AM, Chittayallu RS, et al. A study of the pathogenesis of Helicobacter pylori-negative chronic duodenal ulcer. Gut 1993; 34:762-76.
13. Borody TJ, Brandl S, Andrews P, Jankiewitz E, Ostapovicz N. Helicobacter pylori-negative gastric ulcer. Am J Gastroenterol 1992;87:1403-6.
14. Nensey YM, Schubert TT, Bologna SD, Ma CK. Helicobacter pylori-negative duodenal ulcer. Am J Med 1991;91:15-8.
15. Hyvarinen H, Salmenkylla S, Sipponen P. Helicobacter pylori-negative duodenal and pyloric ulcer: role of NSAIDs. Digestion 1996;57:305-9.
16. Borody TJ, George L, Brandl S. et al. Helicobacter pylori-negative duodenal ulcer. Am J Gastroenterol 1991;86:1154-7.
17. Cryer B, Redfern JS, Goldschmiedt M, Lee E, Feldman M. Effect of aging on gastric and duodenal mucosal prostagiandin concentrations in humans. Gastroenterology 1992;102:1118-23.
18. th ed. Philadelphia: WB Saunders Company, 1993:580-679.
19. Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of campylobacter pylori. Lancet 1988;ii:1437-41.